Rosine Guimbaud

Institut de Recherche en Santé Digestive

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer”.

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

New England Journal of Medicine(2011)10.1056/nejmoa1011923

N/A

1.3DataRank · unranked

6381 citations

Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn +21 more

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Nature Communications(2021)10.1038/s41467-020-20496-3

N/A

0DataRank · unranked

39 citations

Michael Lush, Jonathan Beesley, Tracy A. O’Mara, Joe Dennis, Jonathan P. Tyrer +94 more

PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0521

N/A

0DataRank · unranked

79 citations

Ivan Bièche, Éric Pasmant, Nadim Hamzaoui, Nicolas Leulliot, Lucas Michon +51 more

LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network

Annals of Oncology(2023)10.1016/j.annonc.2023.10.048

N/A

0DataRank · unranked

7 citations

Thierry Lecomte, Julien Hadoux, Patricia Niccoli, Léa Saban-Roche, E. Gaye +15 more